Pharmaceutical outcomes research is a track within the PhD program in Pharmaceutical Sciences. Students who graduate with this track are prepared to conduct high-quality and high-impact patient-oriented or population-based research. We often study the effects of health care and health system interventions on economic, clinical, and humanistic outcomes. Areas of focus available to students undertaking this course of study are pharmacoeconomics, pharmacoepidemiology, health services research, and drug policy.
Core faculty are methodological experts and provide collaborative linkage to clinical experts in all pharmacy, medicine, nursing, and public health. Programs of study are tailored to student interests in disease or drug areas, such as cardiology, psychiatry, neurology, and cancer. Opportunities exist to link to more basic science colleagues depending on your topic of interests. For example, students interested in drug safety might link with toxicology faculty, or in gene-environment interactions might link with pharmacogenomics faculty.
The overall goal of the program is to develop leading experts in the field of pharmaceutical outcomes research. The average time to earn a PhD from the program is 5.5 years.
Admission requirements for the PhD track in pharmaceutical outcomes research.
Based on the rules of the UCD Graduate School, all PhD students in good academic standing are guaranteed financial support.
Frequently asked questions about the PhD track in pharmaceutical outcomes research.
Contact information for the PhD track in pharmaceutical outcomes research